Search Within

Harry W Herr

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (10)
  2. Meeting Abstract (5)
  3. Editorial (1)
Groups
  1. Human Oncology and Pathogenesis Program (16)
  2. Surgery (16)
  3. Urology (16)
  4. Department of Pathology and Laboratory Medicine (15)
  5. Department of Medicine (14)
  6. Genitourinary Oncology Service (14)

More Groups

People
  1. Bernard Bochner (14)
  2. Guido Dalbagni (14)
  3. Hikmat Al-Ahmadie (14)
  4. Dean Bajorin (12)
  5. Eugene Pietzak (12)
  6. Sherri Donat (12)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (2)
  4. 2022 (3)
  5. 2021 (2)
  6. 2019 (1)

More Years

Publications
  1. Journal of Clinical Oncology (6)
  2. JCO Precision Oncology (2)
  3. Urologic Oncology: Seminars and Original Investigations (2)
  4. BJU International (1)
  5. British Journal of Cancer (1)
  6. Clinical Genitourinary Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (8)
  2. Elsevier Inc. (4)
  3. Elsevier Science, Inc. (2)
  4. Nature Publishing Group (1)
  5. Wiley Blackwell (1)

Results (16)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic differences between “primary” and “secondary” muscle-invasive bladder cancer as a basis for disparate outcomes to cisplatin-based neoadjuvant chemotherapy
    Editorial

    Pietzak, E. J.; Zabor, E. C.; Bagrodia, A.; Armenia, J.; Hu, W.; Zehir, A.; Funt, S.; Audenet, F.; Barron, D.; Maamouri, N.; more...
    European Urology (2019)

    Fulltext@MSK | Save
  • Multicenter prospective phase II trial of neoadjuvant dose-dense gemcitabine plus cisplatin in patients with muscle-invasive bladder cancer
    Journal Article

    Iyer, G.; Balar, A. V.; Milowsky, M. I.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Huang, W. C.; Taneja, S. S.; Woods, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma
    Journal Article

    Isharwal, S.; Huang, H.; Nanjangud, G.; Audenet, F.; Chen, Y. B.; Gopalan, A.; Fine, S. W.; Tickoo, S. K.; Lee, B. H.; Iyer, G.; more...
    Human Pathology (2018)

    Fulltext@MSK | Save
  • Differences in somatic DNA damage repair (DDR) gene alterations between primary and secondary muscle invasive bladder cancer (MIBC)
    Meeting Abstract

    Pietzak, E. J.; Bagrodia, A.; Li, Q.; Al-Ahmadie, H.; Herr, H. W.; Funt, S.; Barron, D.; Zehir, A.; Berger, M. F.; Solit, D. B.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy
    Journal Article

    Kim, P. H.; Sukhu, R.; Cordon, B. H.; Sfakianos, J. P.; Sjoberg, D. D.; Hakimi, A. A.; Dalbagni, G.; Lin, O.; Herr, H. W.
    BJU International (2014)

    Fulltext@MSK | Save
  • The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guerin
    Journal Article

    Sfakianos, J. P.; Kim, P. H.; Hakimi, A. A.; Herr, H. W.
    Journal of Urology (2014)

    Fulltext@MSK | Save